Featured Research

from universities, journals, and other organizations

Testosterone Aids Older Men's Brains, UCSF Study Says

Date:
April 16, 2002
Source:
University Of California - San Francisco
Summary:
Older men with higher testosterone levels performed better on tests of cognition in a new study from UCSF researchers. The study suggests that older men who are prescribed testosterone supplements may reduce their risk of cognitive decline, a precursor state to Alzheimer’s disease, the researchers said.

Older men with higher testosterone levels performed better on tests of cognition in a new study from UCSF researchers. The study suggests that older men who are prescribed testosterone supplements may reduce their risk of cognitive decline, a precursor state to Alzheimer’s disease, the researchers said.

Men’s bodies tend to produce less testosterone as they age, and some doctors have begun prescribing supplements of the hormone to increase libido and treat other age-related problems in men.

“The men in the study with higher levels of bioavailable testosterone, the testosterone that can reach the brain, did significantly better on these cognitive tests than men with lower levels,” said lead author Kristine Yaffe, MD, UCSF assistant professor of psychiatry, neurology and epidemiology and biostatistics, and chief of geriatric psychiatry at SFVAMC.

However, Yaffe does not recommend that men begin taking testosterone to improve cognition. “Our study only looked at natural testosterone levels and so it doesn’t prove that testosterone supplements can prevent cognitive decline. We will need results of large randomized clinical trials in older men before we can confidently say that testosterone supplements are beneficial and safe,” she said.

Taking testosterone, or over-the-counter supplements that boost levels of the hormone, can have side effects including increased risk of prostate cancer, increased cholesterol levels, acne and male pattern baldness, Yaffe said. Although some previous studies have suggested that testosterone might benefit the brain, most of these studies were of younger men, she said.

The study, which was published in the April issue of the Journal of the American Geriatrics Society, looked at 300 older men enrolled in a larger study of risk factors for osteoporosis in men that included cognitive testing.

The cognitive tests measured concentration, memory, attention, language, and other cognitive skills. When scores on these tests decline significantly, or are well below average, this serves as a warning of a high risk of Alzheimer’s disease, Yaffe said.

In addition to testosterone, the researchers measured estrogen and sex hormone binding globulin, a protein that binds these two hormones. Although testosterone was linked to better scores on the tests, estrogen had essentially no effect on performance, Yaffe said. Previous studies of women have shown that higher estrogen levels can reduce their risk of cognitive decline.

Other research has shown that men have higher levels of both estrogen and testosterone than women, and that women have a 30 percent greater risk of developing Alzheimer’s Disease, Yaffe said. Some researchers hypothesize that women’s increased Alzheimer’s risk is related to lower hormone levels.

This study doesn’t explain how testosterone acts on the brain, Yaffe said, but other studies of mice have shown that the parts of the brain that handle learning and memory tasks are replete with receptors for testosterone.

In comparing scores, the researchers focused on bioavailable testosterone, which is not bound to the proteins, Yaffe said, because when the hormone is bound to protein it has essentially no effect on the brain.

Co-investigators on the study included: Joseph Zmuda, PhD, assistant professor of epidemiology, and Jane Cauley, DrPH, associate professor of epidemiology, both at University of Pittsburgh; and Lilly Lui, MS, from UCSF Prevention Sciences Group.

The San Francisco Veterans Affairs Medical Center has been a primary affiliate of University of California, San Francisco since 1974. The UCSF School of Medicine and the SFVAMC collaborate to provide education and training programs for medical students and residents at SFVAMC. SFVAMC maintains full responsibility for patient care and facility management of the medical center. Physicians at SFVAMC are employed by the Department of Veterans Affairs and also hold UCSF faculty appointments.


Story Source:

The above story is based on materials provided by University Of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California - San Francisco. "Testosterone Aids Older Men's Brains, UCSF Study Says." ScienceDaily. ScienceDaily, 16 April 2002. <www.sciencedaily.com/releases/2002/04/020416073158.htm>.
University Of California - San Francisco. (2002, April 16). Testosterone Aids Older Men's Brains, UCSF Study Says. ScienceDaily. Retrieved July 26, 2014 from www.sciencedaily.com/releases/2002/04/020416073158.htm
University Of California - San Francisco. "Testosterone Aids Older Men's Brains, UCSF Study Says." ScienceDaily. www.sciencedaily.com/releases/2002/04/020416073158.htm (accessed July 26, 2014).

Share This




More Health & Medicine News

Saturday, July 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins